Panclicins, novel pancreatic lipase inhibitors. II. Structural elucidation

28Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Panclicins A~E are novel and potent pancreatic lipase inhibitors produced by Streptomyces sp. NR 0619. Their structures have been elucidated based on NMR and FAB-MS experiments. The relative configurations have also been determined by NMR experiments. The absolute stereochemistry has been determined by the chiral HPLC analysis of the hydrolysates of panclicins A and B and by modified Mosher's method on a derivative of panclicin A. They are structurally related to β-lactone esterase inhibitors of microbial origin, lipstatin, valilactone, ebelactones and esterastin. Panclicins also contain a β-lactone structure with two alkyl chains, one of which has an N-formylalanyloxy or N-formylglycyloxy substituent. © 1994, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Yoshinari, K., Aoki, M., Ohtsuka, T., Nakayama, N., Itezono, Y., Mutoh, M., … Yokose, K. (1994). Panclicins, novel pancreatic lipase inhibitors. II. Structural elucidation. The Journal of Antibiotics, 47(12), 1376–1384. https://doi.org/10.7164/antibiotics.47.1376

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free